A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
ARTICLE: A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease AUTHORS: Robert A. Scott, Daniel F. Freitag,… Read More »A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease